AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/article-1G1-140989505/novartis-receives-us-approval.html" title="Facts and information about Novartis receives US approval for oral chelate former for iron elimination.">Novartis receives US approval for oral chelate former for iron elimination.</a>
Close
Set up an RSS feed that alerts you when new articles from Chemical Business Newsbase are available.
Frequently asked questions about RSS feeds
Novartis receives US approval for oral chelate former for iron elimination.
(From Chemical Business NewsBase - Die Pharmazeutische Industrie)
Novartis received approval in the US for the world's first registration of Exjade (deferasirox), the first one-a-day iron chelate former. The drug is approved for the treatment of chronic haemosiderosis in adults and children from 2 years old which is caused by blood transfusions. Exjade tablets are dissolved in a glass of orange juice, apple juice or water. …
Related articles from newspapers, magazines, journals, and more
